Live Breaking News & Updates on Lyophilizing Live Vaccine Strains

Stay updated with breaking news from Lyophilizing live vaccine strains. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Appili Therapeutics Announces Issuance of Patent for ATI-1701 Biodefense Vaccine Candidate to Protect Against Tularemia and Provides Update on Bridge Loan

Patent coverage provides drug market exclusivity through at least 2039

Pre-IND meeting with the FDA granted to discuss ATI-1701’s regulatory, CMC, toxicology, and Phase 1 strategies

. ....

United States , Francisella Tularensis , Don Cilla , Us Air Force Academy , Us National Institutes Of Health , Trademark Office , National Research Council Of Canada , Appili Therapeutics Inc , Bloom Burton Co , Defense Threat Reduction Agency , Company Or Appili , Contract Manufacturing Organization , Appili Therapeutics , United States Patent , Lyophilizing Live Vaccine Strains , National Research Council , Chief Executive Officer , Force Academy , Manufacturing Organization , Biological License , Bloom Burton , Bridge Loan , Defense Threat Reduction ,